[18F]AlF-NOTA-PCP2 PET/CT to Assess PD-L1 Status in Head and Neck Cancer: Head-to-Head Comparison With [18F]FDG PET/CT. Wang Y, Liu Z, Li Y, He K, et al. Clin Nucl Med 2026;51:2-12.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Y, Liu Z, Li Y, He K, et al. [18F]AlF-NOTA-PCP2 PET/CT to Assess PD-L1 Status in Head and Neck Cancer: Head-to-Head Comparison With [18F]FDG PET/CT. Clin Nucl Med 2026;51:2-12.
PMID: 41365504